BE550319A - - Google Patents
Info
- Publication number
- BE550319A BE550319A BE550319DA BE550319A BE 550319 A BE550319 A BE 550319A BE 550319D A BE550319D A BE 550319DA BE 550319 A BE550319 A BE 550319A
- Authority
- BE
- Belgium
- Prior art keywords
- emi
- acid
- aralkyl
- aryl
- mixture
- Prior art date
Links
- 239000002253 acid Substances 0.000 claims description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 150000007513 acids Chemical class 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 150000004820 halides Chemical class 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 239000011574 phosphorus Substances 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- QLZHNIAADXEJJP-UHFFFAOYSA-N Phenylphosphonic acid Chemical compound OP(O)(=O)C1=CC=CC=C1 QLZHNIAADXEJJP-UHFFFAOYSA-N 0.000 claims description 2
- 150000003949 imides Chemical class 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical group CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000004494 ethyl ester group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 125000004437 phosphorous atom Chemical group 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 24
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 5
- 239000002585 base Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- -1 phospho Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 125000001931 aliphatic group Chemical class 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ZJEHRMYJNACSLL-UHFFFAOYSA-N 1-[butoxy(chloro)phosphoryl]oxybutane Chemical compound CCCCOP(Cl)(=O)OCCCC ZJEHRMYJNACSLL-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- CLBNGRFUFHAIQI-UHFFFAOYSA-N CCOC(C=CC=C1)=C1P(Cl)(Cl)=O Chemical compound CCOC(C=CC=C1)=C1P(Cl)(Cl)=O CLBNGRFUFHAIQI-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- PKUWKAXTAVNIJR-UHFFFAOYSA-N O,O-diethyl hydrogen thiophosphate Chemical compound CCOP(O)(=S)OCC PKUWKAXTAVNIJR-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical compound OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- NBZANZVJRKXVBH-GYDPHNCVSA-N alpha-Cryptoxanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/[C@H]2C(C)=CCCC2(C)C)\C)/C)\C)/C)=C(C)C1 NBZANZVJRKXVBH-GYDPHNCVSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- ITVPBBDAZKBMRP-UHFFFAOYSA-N chloro-dioxido-oxo-$l^{5}-phosphane;hydron Chemical compound OP(O)(Cl)=O ITVPBBDAZKBMRP-UHFFFAOYSA-N 0.000 description 1
- NNTABFLZUGSQKW-UHFFFAOYSA-N ctk0h9052 Chemical compound NP(N)(Cl)=O NNTABFLZUGSQKW-UHFFFAOYSA-N 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 150000001470 diamides Chemical class 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- VZEGPPPCKHRYGO-UHFFFAOYSA-N diethoxyphosphorylbenzene Chemical group CCOP(=O)(OCC)C1=CC=CC=C1 VZEGPPPCKHRYGO-UHFFFAOYSA-N 0.000 description 1
- LGTLXDJOAJDFLR-UHFFFAOYSA-N diethyl chlorophosphate Chemical compound CCOP(Cl)(=O)OCC LGTLXDJOAJDFLR-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- RTWNYYOXLSILQN-UHFFFAOYSA-N methanediamine Chemical compound NCN RTWNYYOXLSILQN-UHFFFAOYSA-N 0.000 description 1
- AYCXIVOOSPZUOI-UHFFFAOYSA-N n-[chloro(ethoxy)phosphoryl]-n-ethylethanamine Chemical compound CCOP(Cl)(=O)N(CC)CC AYCXIVOOSPZUOI-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 150000003018 phosphorus compounds Chemical class 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/564—Three-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
Description
<EMI ID=1.1> <EMI ID=2.1>
milieu fixant les acides, des composés du phosphore pentavalent contenant de l'halogène, répondant à la formule générale:
<EMI ID=3.1>
<EMI ID=4.1>
alcoyle,, aryle, aralcoyle et cycloalcoyle- ou des radicaux hétérocycliques comprenant plus de trois éléments nucléaires, qui peuvent être identiques ou différents et qui peuvent être
<EMI ID=5.1>
intermédiaire d'oxygène, d'azote ou de soufre, et dans laquelle le symbole X remplace de l'oxygène ou du soufre et
<EMI ID=6.1>
phore formés, de formule:
<EMI ID=7.1>
<EMI ID=8.1>
alcoyle inférieur.
Comme composés monohalogénés entrent en ligne de compte dans
<EMI ID=9.1> tels que le diéthyl-chlorophosphate ou le dibutyl-chlorophosphate, ou bien des esters mixtes et des esters de phénols.
Entrent également en considération des amides des acides
<EMI ID=10.1>
diamide de l'acide chlorophosphorique et'la N,N'-bis-penta= méthylène-diamide de l'acide chlorophosphorique ou des ; dérivés phosphoriques correspondants d'autres amines et de composés cycliques , tels que ceux de la pyrrolidine, de la morphbline ou de l'hexyméthylène-imine. De plus, on peut :aussi partir. d'ester-amides d'acides halogénophosphoriques, par exemple de l'ester éthylique de l'acide diéthylamidochlorophosphorique ou d'amides mixtes. De manière analogue on peut aussi utiliser les esters et amides d'acides halogénophosphoniques, Gomme par exemple le chlorure d'acide éthoxy-phénylphosphonique ou le chlorure d'acide diéthyl-
<EMI ID=11.1>
"acides phénylphosphoniques substitués, d'acides phospho, niques aliphatiques ou cycloaliphatiques. Finalement, on peut aussi employer pour la réaction les halogénures correspondants de l'acide thiophosphorique et de l'acide thiophosphonique,.comme par exemple le chlorure de l'acide diéthylthiophosphorique et d'autres halogénures d'esters, la N,N,-
<EMI ID=12.1>
homologues et les dérivés halogéno-thiophosphoriques correspondants de bases" cycliques, tels que ceux de la pyrrolidine, <EMI ID=13.1>
line, ou des diamides, diesters ou amido-esters d'acides halogéno-thiophosphoriques, ainsi que par exemple les chlo-
<EMI ID=14.1>
esters et amides correspondants d'autres acides halogénothiophosphoniques, dans lesquels le phosphore est lié à des restes aromatiques, aliphatiques ou cycloaliphatiques. Comme composés halogénés s'emploient, conformément à l'invention, de préférence les chlorures et les bromures des dérivés phosphoriques correspondants.
<EMI ID=15.1>
pour 1 mol du composé de phosphore contenant de l'halogène.
On peut exécuter la réaction des composés de phosphore mono-
<EMI ID=16.1>
chlorure de carbone, éther ou dioxane, etc., et en l'occurence on utilisera comme agents fixant les acides, de préférence des bases tertiaires comme la triéthylamine, la diméthylaniline et la pyridine et .leurs homologues, en quan-
<EMI ID=17.1> ammoniaque et des amines primaires ou secondaires. Les bases peuvent en même temps aussi servir de solvants. Quelques-uns des composés halogéno-phosphoriques peuvent aussi être mis en réaction dans un milieu alcoolique ou aqueux, et. dans ce cas entrent en ligne de compte comme agents fixant les acides, en plus de ceux indiqués ci-dessus, aussi des hydroxydes ou carbonates de métaux alcalins. On peut exécuter la réaction dans la même solution qui a servi à préparer le composé halogênophosphorique, sans avoir à isoler ce dernier. Dans ce
<EMI ID=18.1>
simultanément avec cette addition, au moins encore 1 mol d' une base.
lorsque la réaction a 'été exécutée en solution aqueuse le produit est séparé de la solution aqueuse réactionnelle au moyen d'un solvant organique, de préférence -par extraction. Autrement, on le sépare des autres produits r�actionnels, en particulier des hydrates halogénés ou halogénures des agents fixant les acides, par filtration ou essorage, ou bien on précipite ceux-ci, après concentration, avec un solvant approprié. Les monoéthylène-imides sont ensuite isolés par évaporation du solvant et éventuellement purifiés par distillation dans le haut vide.
Les dérivés des acides phosphoriques ou des acides phosphoniques se dissolvent ou se mélangent la.plupart du temps bien avec de l'eau, et des solvants contenant des groupes hydroxyles, ainsi qu'avec les solvants organiques usuels"
<EMI ID=19.1>
hydrocarbures, des éthers et, par exemple ,. la diméthylformamide, mais non pas avec de l'eau et souvent pas non plus avec des alcools.
Dans les expériences sur l'animal on a constaté que quelquesuns des,composés conformes à l'invention possèdent la propriété d'inhiber la croissance pathogène des cellules.
Exemple 1
<EMI ID=20.1>
mélange encore durant une demi-heure à 25[deg.]C et on sépare par succion le chlorhydrate de triéthylamine. On fait évaporer le filtrat dans le vide et on essore de nouveau par succion. Par distillation dans le haut vide on obtient un liquide
<EMI ID=21.1>
ment 144 g).
_Exemple 2:
Par réaction de 40 g d'éthylène-imine, 100 g de triéthylamine
<EMI ID=22.1>
point d'ébullition de 88[deg.]0/0,03, le mode opératoire étant le même que celui de l'exemple 1. Ce composé possède des propriétés de solubilité; semblables à celles du produit obtenu
<EMI ID=23.1>
Exemple 30
<EMI ID=24.1>
29 g d'éthylène-imine, 71 g de triéthylamine et 500 cc de benzène, en'agitant. En achevant le traitement de la manière <EMI ID=25.1>
fois l'addition achevée, on ajoute 100 ce de benzène, on agite le mélange encore durant une demi-heure, on sépare les deux couches, on extrait la couche aqueuse à deux. reprises par agitation avec du benzène et on sèche les extraits benzéniques réunis sur du sulfate de sodium. Après évaporation dans le vide, on obtient l'ester diéthylique de l'acide diméthylène-amido-thiophosphorique sous la forme d'un liquide
<EMI ID=26.1>
100 g).
On obtient le même produit si, au lieu dé la solution de carbonate de soude, on utilise une solution de 25 g d'
<EMI ID=27.1>
ammoniaque aqueuse diluée.
Exemple 5:
<EMI ID=28.1>
succion le chlorure de sodium formé et on fait évaporer le filtrat dans le vide. Par distillation dans le haut vide, on
<EMI ID=29.1>
<EMI ID=30.1>
aminé et 400 cc d'éther absolu. Après avoir agité le mélange pendant plusieurs heures, on achevé le traitement comme décrit à l'exemple 1 et on obtient la triamide de l'acide
<EMI ID=31.1>
<EMI ID=32.1>
l'exemple 1, on obtient la triamide de l'acide N-diméthylène-
<EMI ID=33.1>
de 110[deg.]C sous 0,01 mm Hg. (Rendement: 105 g).
Exemple 8
<EMI ID=34.1>
tion de 115,5 g de chlorure d'acide diéthylamido-phénylthiophosphonique. dans 200 ce de benzène. Après avoir achevé <EMI ID=35.1>
le point d'ébullition de 122 - 126o0 sous 0,03 mm Hg.
(Rendement: 10 g).
Exemple 9
<EMI ID=36.1>
amine et 300 ce de benzène. Après avoir achevé le traitement comme décrit à l'exemple 1 , on obtient l'amide de l'acide
<EMI ID=37.1>
de benzène on ajoute goutte à goutte à 20[deg.]C, en agitant,
135,5 g de chlorure d'acide diéthylamido-phénylphosphonique dans 200 ce de benzène. Après avoir achevé le traitement comme indiqué à 1.'exemple 1, on obtient la diamide de l'acide
<EMI ID=38.1>
ébullition de 106 - 108[deg.]C sous 0,01 mm Hg, miscible avec une quantité abondante d'eau et bien soluble dans le propylèneglycol. (Rendement: 111 g).
<EMI ID = 1.1> <EMI ID = 2.1>
Acid-binding medium of halogen-containing pentavalent phosphorus compounds having the general formula:
<EMI ID = 3.1>
<EMI ID = 4.1>
alkyl, aryl, aralkyl and cycloalkyl- or heterocyclic radicals comprising more than three nuclear elements, which may be the same or different and which may be
<EMI ID = 5.1>
intermediate of oxygen, nitrogen or sulfur, and in which the symbol X replaces oxygen or sulfur and
<EMI ID = 6.1>
phore formed, of formula:
<EMI ID = 7.1>
<EMI ID = 8.1>
lower alkyl.
As monohalogen compounds are taken into account in
<EMI ID = 9.1> such as diethyl-chlorophosphate or dibutyl-chlorophosphate, or mixed esters and esters of phenols.
Also taken into consideration are amides of acids
<EMI ID = 10.1>
chlorophosphoric acid diamide and N, N'-bis-penta = chlorophosphoric acid methylene diamide or; corresponding phosphoric derivatives of other amines and cyclic compounds, such as those of pyrrolidine, morphbline or hexymethylene imine. In addition, we can: also leave. halogenophosphoric acid ester-amides, for example diethylamidochlorophosphoric acid ethyl ester or mixed amides. In an analogous manner, it is also possible to use esters and amides of halogenophosphonic acids, for example, ethoxy-phenylphosphonic acid chloride or diethyl-acid chloride.
<EMI ID = 11.1>
"Substituted phenylphosphonic acids, phospho, aliphatic or cycloaliphatic acids. Finally, the corresponding halides of thiophosphoric acid and thiophosphonic acid, such as, for example, chloride of diethylthiophosphoric acid, can also be used for the reaction. and other ester halides, N, N, -
<EMI ID = 12.1>
homologs and the corresponding halo-thiophosphoric derivatives of "cyclic bases, such as those of pyrrolidine, <EMI ID = 13.1>
line, or diamides, diesters or amido-esters of halo-thiophosphoric acids, as well as for example chlo-
<EMI ID = 14.1>
corresponding esters and amides of other halothiophosphonic acids, in which the phosphorus is bound to aromatic, aliphatic or cycloaliphatic residues. As halogenated compounds are employed, in accordance with the invention, preferably chlorides and bromides of the corresponding phosphoric derivatives.
<EMI ID = 15.1>
per 1 mol of the halogen-containing phosphorus compound.
The reaction of mono- phosphorus compounds can be carried out.
<EMI ID = 16.1>
carbon chloride, ether or dioxane, etc., and in this case, as acid-binding agents, tertiary bases such as triethylamine, dimethylaniline and pyridine and their homologs, in quanti-
<EMI ID = 17.1> ammonia and primary or secondary amines. The bases can also serve as solvents at the same time. Some of the halo-phosphoric compounds can also be reacted in an alcoholic or aqueous medium, and. in this case, in addition to those indicated above, also alkali metal hydroxides or carbonates are taken into account as acid-binding agents. The reaction can be carried out in the same solution which was used to prepare the halogenophosphorus compound, without having to isolate the latter. In this
<EMI ID = 18.1>
simultaneously with this addition, at least a further 1 mol of a base.
when the reaction has been carried out in aqueous solution the product is separated from the aqueous reaction solution by means of an organic solvent, preferably by extraction. Otherwise, it is separated from the other reactive products, in particular the halogenated hydrates or halides of the acid-binding agents, by filtration or dewatering, or else they are precipitated, after concentration, with a suitable solvent. The monoethylene imides are then isolated by evaporation of the solvent and optionally purified by distillation in a high vacuum.
The derivatives of phosphoric acids or phosphonic acids dissolve or mix mostly well with water, and solvents containing hydroxyl groups, as well as with usual organic solvents "
<EMI ID = 19.1>
hydrocarbons, ethers and, for example,. dimethylformamide, but not with water and often not with alcohols either.
In animal experiments it has been found that some of the compounds according to the invention possess the property of inhibiting the pathogenic growth of cells.
Example 1
<EMI ID = 20.1>
mix again for half an hour at 25 [deg.] C and the triethylamine hydrochloride is separated by suction. The filtrate is evaporated in vacuo and again filtered off with suction. By high vacuum distillation a liquid is obtained
<EMI ID = 21.1>
ment 144 g).
_Example 2:
By reaction of 40 g of ethylene imine, 100 g of triethylamine
<EMI ID = 22.1>
boiling point of 88 [deg.] 0 / 0.03, the procedure being the same as that of Example 1. This compound has solubility properties; similar to those of the product obtained
<EMI ID = 23.1>
Example 30
<EMI ID = 24.1>
29 g of ethylene-imine, 71 g of triethylamine and 500 cc of benzene, with stirring. By completing processing in the manner <EMI ID = 25.1>
Once the addition is complete, 100 cc of benzene are added, the mixture is stirred for a further half hour, the two layers are separated, the aqueous layer is extracted in pairs. taken up by stirring with benzene and the combined benzene extracts are dried over sodium sulfate. After evaporation in a vacuum, the diethyl ester of dimethylene-amido-thiophosphoric acid is obtained in the form of a liquid.
<EMI ID = 26.1>
100 g).
The same product is obtained if, instead of the sodium carbonate solution, a solution of 25 g of sodium hydroxide is used.
<EMI ID = 27.1>
dilute aqueous ammonia.
Example 5:
<EMI ID = 28.1>
the sodium chloride formed is sucked off and the filtrate is evaporated in vacuo. By high vacuum distillation, we
<EMI ID = 29.1>
<EMI ID = 30.1>
amine and 400 cc of absolute ether. After stirring the mixture for several hours, the treatment is completed as described in Example 1 and the acid triamide is obtained.
<EMI ID = 31.1>
<EMI ID = 32.1>
Example 1, N-dimethylene- acid triamide is obtained
<EMI ID = 33.1>
of 110 [deg.] C at 0.01 mm Hg. (Yield: 105 g).
Example 8
<EMI ID = 34.1>
tion of 115.5 g of diethylamido-phenylthiophosphonic acid chloride. in 200 cc of benzene. After completing <EMI ID = 35.1>
the boiling point of 122 - 126o0 under 0.03 mm Hg.
(Yield: 10 g).
Example 9
<EMI ID = 36.1>
amine and 300 cc of benzene. After completing the treatment as described in Example 1, the amide of the acid is obtained.
<EMI ID = 37.1>
of benzene is added dropwise at 20 [deg.] C, with stirring,
135.5 g of diethylamido-phenylphosphonic acid chloride in 200 cc of benzene. After completing the treatment as indicated in Example 1, the diamide of the acid is obtained.
<EMI ID = 38.1>
boiling at 106-108 [deg.] C at 0.01 mm Hg, miscible with an abundant quantity of water and well soluble in propylene glycol. (Yield: 111 g).
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEF13220A DE963876C (en) | 1953-11-13 | 1953-11-13 | Process for the preparation of mono-ª ‡ ú¼ ª ‰ -alkylenimido-phosphorus compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BE550319A true BE550319A (en) |
Family
ID=7087236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE550319D BE550319A (en) | 1953-11-13 |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE550319A (en) |
DE (1) | DE963876C (en) |
FR (1) | FR1174704A (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1082266B (en) * | 1958-04-05 | 1960-05-25 | Benckiser Gmbh Joh A | Process for the preparation of N-substituted amidophosphoric acid dialkyl esters |
DE1087130B (en) * | 1958-04-23 | 1960-08-18 | Bayer Ag | Process for the preparation of Thionophosphinsaeureaethylenimiden |
BE588254A (en) * | 1959-03-03 | 1900-01-01 | ||
US3136754A (en) * | 1962-05-18 | 1964-06-09 | Olin Mathieson | Aziridinyl-halocyclotriphosphaza-1, 3, 5-trienes |
US3207661A (en) * | 1963-01-11 | 1965-09-21 | American Agricultural Chem Co | Bis-(aziridinyl)-phosphinothioic esters as chemical sterilants for insects and mites |
CH570113A5 (en) * | 1972-07-13 | 1975-12-15 | Ciba Geigy Ag | |
US5232895A (en) * | 1991-11-12 | 1993-08-03 | Imperial Chemical Industries Plc | Alkylphosphonodiamide herbicides |
US5186733A (en) * | 1991-11-12 | 1993-02-16 | Imperial Chemical Industries Plc | Arylphosphonodiamide compounds and herbicidal compositions thereof |
US5189169A (en) * | 1991-11-12 | 1993-02-23 | Imperial Chemical Industries Plc | Phosphorodiamidothioate herbicides |
US5205852A (en) * | 1991-11-12 | 1993-04-27 | Imperial Chemical Industries Plc | Alkylphosphonamidate herbicides |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE854651C (en) * | 1945-01-11 | 1952-11-06 | Hoechst Ag | Process for the preparation of ethyleneimine compounds |
DE888853C (en) * | 1948-10-02 | 1953-09-07 | Hoechst Ag | Process for the preparation of ethyleneimine compounds |
US2654738A (en) * | 1952-08-02 | 1953-10-06 | American Cyanamid Co | Organic derivatives of phosphonic acids and method of preparing the same |
-
0
- BE BE550319D patent/BE550319A/fr unknown
-
1953
- 1953-11-13 DE DEF13220A patent/DE963876C/en not_active Expired
-
1956
- 1956-08-16 FR FR1174704D patent/FR1174704A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE963876C (en) | 1957-05-16 |
FR1174704A (en) | 1959-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE550319A (en) | ||
EP0110781A1 (en) | Substituted (amino-2-ethyl)-6-benzoxazolinones, their preparation and a pharmaceutical composition containing them | |
EP0195734A2 (en) | Preparation of herbicides bearing phosphonate groups and of intermediates from benzoxazines | |
EP0459887A1 (en) | Pyrazole-orthodialkyl-benzamide derivatives with an anticonvulsive activity, process for preparation and pharmaceutical composition | |
US11905250B2 (en) | Methods for preparation of jasmonate compounds | |
BE1004089A3 (en) | DERIVATIVES (N-Methyl-N-alkyl) 3-Amino-2 PROPANE methoxymethylenemalonic 1-OL, A METHOD OF PREPARATION THEREOF SAME AND THERAPEUTIC COMPOSITIONS CONTAINING. | |
FR2615854A1 (en) | NOVEL (O-AMMONIO ACYLOXY METHYLENE) -5-TETRAHYDROFURANES AND TETRAHYDROTHIOPHENES AND METHOD FOR THEIR PREPARATION | |
FR2516514A1 (en) | AZINO RIFAMYCIN COMPOUNDS | |
SU541428A3 (en) | Method for producing glycol ethers | |
FR2479831A1 (en) | THIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
JP2905931B2 (en) | Process for producing optically active 2-cyclopentenones | |
FR2591598A1 (en) | New ceph-3-em-4-carboxylic acid derivatives, their preparation and medicaments containing them | |
KR810000738B1 (en) | Process for preparing 5-alkoxy picolinic acid ester | |
KR940009935B1 (en) | N-benzoyl-c-thiophenoxyimidoyl chloride derivatives and manufacturing method thereof | |
EP0288647B1 (en) | Derivatives of 5-[2-(1-pyrrolidinyl)ethoxy]-p-cymene, process for their preparation, and medicaments containing these derivatives | |
EP0135444A1 (en) | Pyroglumatic derivatives, process for their preparation , intermediates and bactericidal and/or fungicidal cosmetic or pharmaceutical compositions | |
EP0091078B1 (en) | A process for the preparation of derivatives of 2-diethylamino-1-methyl ethyl cis-1-hydroxy-(bicyclohexyl)-2-carboxylate | |
KR0129789B1 (en) | N-alloy-c-(n-methylanilino)imidoyl chloride derivatives and the process of production thereof | |
SU222372A1 (en) | METHOD FOR PRODUCING N-CARBETOXYMETHYLKARBA- ETHER | |
BE865832R (en) | ACETIC ACID ACTIVE DERIVATIVES, THERAPEUTIC COMPOSITIONS CONTAINING THEM AND THE PROCESSES FOR THE PREPARATION OF THESE DERIVATIVES AND COMPOSITIONS | |
FR3055627A1 (en) | METHOD OF PREPARING CDB-3877 COMPOUND | |
BE628231A (en) | ||
BE890221A (en) | NOVEL ESTERS OF ACID (+) 6-METHOXY-ALPHA-METHYL-2-NAPHTHALENEACETIQUE | |
BE552284A (en) | ||
BE837320A (en) | 3-AMINO-1,2-PROPANODIOL ETHER DERIVATIVES |